Working... Menu
Trial record 6 of 11 for:    Cavernous Malformation

Effect of Oral Propranolol on mRNA Expresssion in Symptomatic Cavernous Malformation

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03474614
Recruitment Status : Recruiting
First Posted : March 22, 2018
Last Update Posted : March 22, 2018
Information provided by (Responsible Party):
Norissa Honea, St. Joseph's Hospital and Medical Center, Phoenix

No Study Results Posted on for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : January 24, 2020
  Estimated Study Completion Date : August 30, 2020